Search Results - Yating Dian

  • Showing 1 - 16 results of 16
Refine Results
  1. 1

    Immunophenotyping characteristics and outcome of COVID‐19 patients: peripheral blood CD8+T cell as a prognostic biomarker for patients with Nirmatrelvir by Yuming Sun, Yuming Sun, Yuming Sun, Yuming Sun, Yuming Sun, Yuming Sun, Yating Dian, Yating Dian, Yating Dian, Yating Dian, Yating Dian, Qian Gao, Qian Gao, Qian Gao, Qian Gao, Qian Gao, Qian Gao, Guangtong Deng, Guangtong Deng, Guangtong Deng, Guangtong Deng, Guangtong Deng

    Published in Frontiers in Immunology (2023-09-01)
    Get full text
    Article


  2. 2

    Association of eosinopenia with worsening prognosis in hospitalized Azvudine-treated COVID-19 patients: a retrospective cohort study by Xiaomin Wang, Xiaomin Wang, Xiaomin Wang, Xiaomin Wang, Xiaomin Wang, Xiaomin Wang, Xiaomin Wang, Yating Dian, Yating Dian, Yating Dian, Yating Dian, Yating Dian, Qian Zhou, Qian Zhou, Qian Zhou, Qian Zhou, Qian Zhou, Guangtong Deng, Guangtong Deng, Guangtong Deng, Guangtong Deng, Guangtong Deng, Rui Wei, Rui Wei, Furong Zeng, Furong Zeng

    Published in Frontiers in Immunology (2023-12-01)
    Get full text
    Article


  3. 3

    Response to comment on: “Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis” by Danyao Chen, Yuming Sun, Yating Dian, Guangtong Deng

    Published in Human Vaccines & Immunotherapeutics (2024-12-01)
    Get full text
    Article


  4. 4

    Lactate dehydrogenase predicts disease progression outcome in COVID-19 patients treated with Azvudine by Manyun Mao, Manyun Mao, Manyun Mao, Manyun Mao, Manyun Mao, Yating Dian, Yating Dian, Yating Dian, Yating Dian, Yating Dian, Yuming Sun, Yuming Sun, Yuming Sun, Yuming Sun, Yuming Sun, Wangqing Chen, Wangqing Chen, Wangqing Chen, Wangqing Chen, Wangqing Chen, Wu Zhu, Wu Zhu, Wu Zhu, Wu Zhu, Wu Zhu, Guangtong Deng, Guangtong Deng, Guangtong Deng, Guangtong Deng, Guangtong Deng

    Get full text
    Article


  5. 5

    Efficacy and safety of tebentafusp in patients with metastatic uveal melanoma: A systematic review and meta-analysis by Yating Dian, Yihuang Liu, Furong Zeng, Yuming Sun, Guangtong Deng

    Published in Human Vaccines & Immunotherapeutics (2024-12-01)
    Get full text
    Article


  6. 6

    Immune checkpoint inhibitors in cancer patients with autoimmune disease: Safety and efficacy by Jiayuan Le, Yuming Sun, Guangtong Deng, Yating Dian, Yanli Xie, Furong Zeng

    Published in Human Vaccines & Immunotherapeutics (2025-12-01)
    Get full text
    Article


  7. 7

    Clinical characteristics and risk factors for ZF2001 fully vaccinated inpatients with COVID-19: A retrospective cohort study by Liping Jin, Yating Dian, Yuming Sun, Guangtong Deng, Chaofei Han, Furong Zeng

    Published in Human Vaccines & Immunotherapeutics (2024-12-01)
    Get full text
    Article


  8. 8

    Corrigendum to ‘Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort study.’ [EClinicalMedicine 59 (2023) 101981] by Yuming Sun, Liping Jin, Yating Dian, Minxue Shen, Furong Zeng, Xiang Chen, Guangtong Deng

    Published in EClinicalMedicine (2023-08-01)
    Get full text
    Article


  9. 9

    Oral Azvudine for hospitalised patients with COVID-19 and pre-existing conditions: a retrospective cohort studyResearch in context by Yuming Sun, Liping Jin, Yating Dian, Minxue Shen, Furong Zeng, Xiang Chen, Guangtong Deng

    Published in EClinicalMedicine (2023-05-01)
    Get full text
    Article


  10. 10

    Single-cell multi-omics in cancer immunotherapy: from tumor heterogeneity to personalized precision treatment by Jiayuan Le, Yating Dian, Deze Zhao, Ziyu Guo, Zehao Luo, Xiang Chen, Furong Zeng, Guangtong Deng

    Published in Molecular Cancer (2025-08-01)
    Get full text
    Article


  11. 11

    Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy by Deze Zhao, Yu Meng, Yating Dian, Qian Zhou, Yuming Sun, Jiayuan Le, Furong Zeng, Xiang Chen, Yi He, Guangtong Deng

    Published in Redox Biology (2023-12-01)
    Get full text
    Article


  12. 12

    The molecular mechanism and therapeutic landscape of copper and cuproptosis in cancer by Ziyu Guo, Danyao Chen, Lei Yao, Yuming Sun, Daishi Li, Jiayuan Le, Yating Dian, Furong Zeng, Xiang Chen, Guangtong Deng

    Published in Signal Transduction and Targeted Therapy (2025-05-01)
    Get full text
    Article


  13. 13

    Ferroptosis: mechanisms and therapeutic targets by Qian Zhou, Yu Meng, Jiayuan Le, Yuming Sun, Yating Dian, Lei Yao, Yixiao Xiong, Furong Zeng, Xiang Chen, Guangtong Deng

    Published in MedComm (2024-12-01)
    Get full text
    Article


  14. 14

    Targeting oxidative stress-mediated regulated cell death as a vulnerability in cancer by Danyao Chen, Ziyu Guo, Lei Yao, Yuming Sun, Yating Dian, Deze Zhao, Yizhe Ke, Furong Zeng, Chunfang Zhang, Guangtong Deng, Linfeng Li

    Published in Redox Biology (2025-07-01)
    Get full text
    Article


  15. 15

    Propafenone facilitates mitochondrial-associated ferroptosis and synergizes with immunotherapy in melanoma by Hong Liu, Qian Zhou, Yi He, Xiang Chen, Hui Su, Yu Meng, Yating Dian, Lei Yao, Yuming Sun, Daishi Li, Yixiao Xiong, Furong Zeng, Xiaowei Liang, Guangtong Deng

    Published in Journal for ImmunoTherapy of Cancer (2024-11-01)
    Get full text
    Article


  16. 16

    Ubiquitin‐specific protease 22 controls melanoma metastasis and vulnerability to ferroptosis through targeting SIRT1/PTEN/PI3K signaling by Huiyan Sun, Yu Meng, Lei Yao, Songtao Du, Yayun Li, Qian Zhou, Yihuang Liu, Yating Dian, Yuming Sun, Xiaomin Wang, Xiao‐wei Liang, Guangtong Deng, Xiang Chen, Furong Zeng

    Published in MedComm (2024-08-01)
    Get full text
    Article


Search Tools: